Interesting company imo with a low market cap of ~$9.6 Million. I am currently waiting for a possible lower entry point. Cash at hand should be sufficent for the next 12 months. The price can move quick upon good news. Artelo Biosciences, Inc. (NASDAQ: ARTL) is a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate endogenous signaling pathways, including the endocannabinoid system. https://ir.artelobio.com/ 8/31/2020 Fiscal Year End Cash Balance $2.1M 10/14/2020 Net Proceeds from Public Offering $6.6M
Artelo Biosciences Reports First Quarter Fiscal Year 2021 Financial Results and Provides Business Update January 14, 2021 8:30am EST Received Clinical Trial Authorization to Commence Cancer Appetite Recovery Phase I/II Clinical Study of ART27.13 in UK Awarded Mitacs Accelerate Grant https://ir.artelobio.com/news-event...iences-reports-first-quarter-fiscal-year-2021
Artelo Biosciences Announces Research Collaboration with Trinity College Dublin to Investigate ART27.13 for the Treatment of Cancer Cachexia February 02, 2021 https://ir.artelobio.com/news-event...ciences-announces-research-collaboration-with
